PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15458278-2	2004	The study found that beta2-AR agonists inhibited the expression of intercellular adhesion molecule-1 (ICAM-1), CD40 and CD14 on monocytes, and that AR agonist activity was antagonized by the selective beta2-AR antagonist, butoxamine.	Butoxamine	222-232	adrenoceptor beta 2	Homo sapiens	201-209	
19106745-3	2009	METHODS: The beta-adrenoceptor antagonist propranolol, beta1-adrenoceptor antagonist metoprolol, and beta2-adrenoceptor antagonist butoxamine were used to induce apoptosis in PC-2 cells.	Butoxamine	131-141	adrenoceptor beta 2	Homo sapiens	101-119	
15458278-2	2004	The study found that beta2-AR agonists inhibited the expression of intercellular adhesion molecule-1 (ICAM-1), CD40 and CD14 on monocytes, and that AR agonist activity was antagonized by the selective beta2-AR antagonist, butoxamine.	Butoxamine	222-232	adrenoceptor beta 2	Homo sapiens	21-29	
15998544-2	2005	The study found that beta2-AR agonists inhibited IL-18 and IL-12 production in monocytes, and that AR agonist activity was antagonized by the selective beta2-AR antagonist, butoxamine.	Butoxamine	173-183	adrenoceptor beta 2	Homo sapiens	21-29	
15998544-2	2005	The study found that beta2-AR agonists inhibited IL-18 and IL-12 production in monocytes, and that AR agonist activity was antagonized by the selective beta2-AR antagonist, butoxamine.	Butoxamine	173-183	adrenoceptor beta 2	Homo sapiens	152-160	
15908512-10	2005	In contrast, the selective beta2AR antagonists ICI-118,551 and butoxamine inhibited isoproterenol-mediated enhancement with apparent low affinities (K(b) of 222 +/- 61 and 9268 +/- 512 nM, respectively).	Butoxamine	63-73	adrenoceptor beta 2	Homo sapiens	27-34	
15145612-2	2004	All responses by these stimulations were antagonized by the selective beta 2-adrenergic receptor (AR) antagonist, butoxamine, but not by alpha 1-, alpha 2- and beta 1-AR antagonists.	Butoxamine	114-124	adrenoceptor beta 2	Homo sapiens	70-96	
6257884-2	1981	Beta-1 and beta-2 adrenergic receptor blockade were produced with atenolol and butoxamine, respectively.	Butoxamine	79-89	adrenoceptor beta 2	Homo sapiens	11-37	
10924081-4	2000	Results from using an in vitro tissue bath technique indicated that propranolol and preferential beta(2)-adrenoceptor antagonists (ICI-118,551 and butoxamine), in a concentration-dependent manner, blocked the relaxation induced by nicotine (100 microM) without affecting the relaxation elicited by transmural nerve stimulation (TNS, 8 Hz).	Butoxamine	147-157	adrenoceptor beta 2	Homo sapiens	97-117	
7600375-6	1995	The potentiating effect of salbutamol on IgE production was blocked by two antagonists of beta 2-adrenoceptor, namely butoxamine and D,L-propranolol, suggesting a beta-adrenoceptor-mediated event.	Butoxamine	118-128	adrenoceptor beta 2	Homo sapiens	90-109	
33622325-10	2021	Gene silencing of the beta2-adrenergic receptor in NCI-H292 negated the ability of olodaterol to inhibit IL-8 secretion from both RSV infection and lipopolysaccharide stimulus, as did blocking of the receptor with ICI 118,551 and butaxamine.	Butoxamine	230-240	adrenoceptor beta 2	Homo sapiens	22-47	
31743979-8	2019	The hippocampal neurogenesis elicited by a 7-day exercise regimen was abolished by a selective inhibitor of beta2-AR, butoxamine.	Butoxamine	118-128	adrenoceptor beta 2	Homo sapiens	108-116